BPH - Benign Prostatic Enlargement - Results from #30

Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand? November 18, 2024

Search trends in the treatment for benign prostatic hyperplasia: A twenty-year analysis. November 15, 2024

Prostate Artery Embolization - Mid to Long-term Outcomes in 1075 Patients. November 15, 2024

Urinary Retention After GreenLight Laser Photoselective Vaporization of the Prostate (GLL.PVP) Surgery for Benign Prostatic Hyperplasia (BPH): A 3-6 Month Retrospective Follow-Up Study. November 15, 2024

WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm3 and 80-150-cm3 prostates. November 15, 2024

Efficacy and safety of prostatic urethral lift according to preoperative urinary retention and prostate volume: A Japanese real-world multicenter data. November 10, 2024

Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland. November 10, 2024

Open simple prostatectomy in the last three decades: results of a meta-analysis. November 10, 2024

Does size matter? A single institution's comparison of Aquablation in prostates greater than or less than 150 mL. November 4, 2024

The Association Between Solid Fuel Use and Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Sichuan, China: Cross-Sectional Study. November 3, 2024

A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study. November 3, 2024

Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic. November 3, 2024

NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells. October 24, 2024

Short-term postoperative recovery for patients after Thulium Laser Vapoenucleation of Prostate: evaluation of the impact of lower urinary tract symptoms on quality of life. October 24, 2024

Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. October 24, 2024

Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. October 21, 2024

Teverelix is a potential treatment option for the prevention of acute urinary retention recurrence in men suffering from benign prostatic hyperplasia. October 21, 2024

Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function. October 18, 2024

Second-generation MOSES 2.0 versus MOSES 1.0 pulse-modulation technologies for holmium laser enucleation of the prostate (HoLEP). October 18, 2024

Predictors of symptomatic relief in water vapor thermal therapy for prostatic hyperplasia: 36-month prospective study. October 18, 2024

Page 2 of 142